SEARCH

SEARCH BY CITATION

LITERATURE CITED

  • 1
    Mandy F. CD4: 20 years and counting. Cytometry (Clin Cytometry) 2002; 50: 39132.
  • 2
    Mandy F,Nicholson J,Autran B,Janossy G. T-cell subset counting and the fight against AIDS: Reflections over a 20-year struggle. Cytometry (Clin Cytometry) 2002; 50: 3945.
  • 3
    Janossy G,Barry SM,Breen RAM,Hardy GA,Lipman M,Kern F. The role of clinical flow cytometry in the interferon-γ based diagnosis of active tuberculosis and its co-infection with HIV-1—A technically oriented review. Cytometry Part B (Clin Cytometry) 2008; 74B ( Suppl). In press. doi: 10.1002/cyto.b.20381 (this issue).
  • 4
    Shapiro HM,Perlmutter NG. ‘Killer’ applications: Towards affordable rapid cell-based diagnostics for malaria and tuberculosis. Cytometry Part B (Clin Cytometry) 2008; 74B ( Suppl). In press. doi: 10.1002/cyto.b.20401 (this issue).
  • 5
    Gottlieb MS,Schroff R,Schanker HM,Weisman JD,Fan PT,Wolf RA,Saxon A. Pneumocystis carinii pneumonia and mucosal candidiasis in previously healthy homosexual men: Evidence of a new acquired cellular immunodeficiency. New Engl J Med 1981; 305: 14251431.
  • 6
    Shapiro HM. Practical Flow Cytometry, 4th ed. New York: Wiley-Liss; 2003.
  • 7
    Keating P,Cambrosio A. Biomedical Platforms—Realigning the Normal and the Pathological in Late-Twentieth-Century Medicine. London: MIT; 2003.
  • 8
    Fahey JL,Taylor JM,Detels R,Hofmann B,Melmed R,Nishanian P,Giorgi JV. The prognostic value of cellular and serologic markers in infection with human immunodeficiency virus type 1. N Engl J Med 1990; 322: 166172.
  • 9
    Schnizlein-Bick CT,Mandy FF,O'Gorman MR,Paxton H,Nicholson JK,Hultin LE,Gelman RS,Wilkening CL,Livnat D. Use of CD45 gating in three and four-color flow cytometric immunophenotyping: Guideline from the National Institute of Allergy and Infectious Diseases. Division of AIDS. Cytometry (Clin Cytometry) 2002; 50: 4652.
  • 10
    Whitby L,Granger V,Storie I,Goodfellow K,Sawle A,Reilly JT,Barnett D. Quality control of CD4+ T-lymphocyte enumeration: Results from the last 9 years of the UK National External Quality Assessment Scheme for Immune Monitoring. Cytometry (Clin Cytometry) 2002; 50: 102110.
  • 11
    Mandy F,Bergeron M,Houle G,Bradley J,Fahey J. Impact of the international program for Quality Assessment and Standardization for Immunological Measures Relevant to HIV/AIDS: QASI. Cytometry (Clin Cytometry). 2002; 50: 111116.
  • 12
    Perfetto SP,Chattopadhyay PK,Roederer M. Seventeen-colour flow cytometry: Unravelling the immune system. Nat Rev Immunol 2004; 4: 648655.
  • 13
    Krutzik PO,Nolan GP. Fluorescent cell barcoding in flow cytometry allows high-throughput drug screening and signaling profiling. Nat Methods 2006; 3: 361368.
  • 14
    Szczepánski T. Why and how to quantify minimal residual disease in acute lymphoblastic leukemia? Leukemia 2007; 21: 622626.
  • 15
    Perfetto SP,Ambrozak D,Nguyen R,Chattopadhyay P,Roederer M. Quality assurance for polychromatic flow cytometry. Nat Protocol 2006; 1: 15221530.
  • 16
    Herzenberg LA,Tung J,Moore WA,Herzenberg LA,Parks DR. Interpreting flow cytometry data: A guide for the perplexed. Nat Immunol 2006; 7: 681685.
  • 17
    Mandy FF,Nicholson JK,McDougal JS. Guidelines for performing single-platform absolute CD4+ T-cell determinations with CD45 gating for persons infected with human immunodeficiency virus. Centers for Disease Control and Prevention. MMWR Recomm Rep 2003; 52: 113.
  • 18
    Janossy G,Jani IV,Kahan M,Barnett D,Mandy F,Shapiro H. Precise CD4 T-cell counting using red diode laser excitation: For richer, for poorer. Cytometry (Clin Cytometry) 2002; 50: 7885.
  • 19
    Glencross DK,Janossy G,Coetzee LM,Lawrie D,Aggett HM,Scott LE,Sanne I,McIntyre J,Stevens W. Large-scale affordable panleucogated CD4+ testing with proactive internal- and external quality assessment—in support of the South African National Comprehensive Care, Treatment, and Management Programme for HIV/AIDS. Cytometry Part B (Clin Cytometry) 2008; 74B ( Suppl): in press. doi: 10.1002/cyto.b.20384 (this issue).
  • 20
    Sippy-Chatrani N,Marshall S,Branch S,Carmichael-Simmons K,Landis C,Abayomi A. Performance of the panleucogating protocol for CD4+ T cell enumeration in an HIV dedicated laboratory facility in Barbados. Cytometry Part B (Clin Cytometry) 2008; 74B ( Suppl). In press. doi: 10.1002/cyto.b.20406 (this issue).
  • 21
    Denny TN,Gelman R,Bergeron M,Forman M,Landay A,Louzao R,Mandy F,Schmitz J,Wilkening C,Glencross DK. A multi-laboratory study of CD4 counts using Flow Cytometric PanLeukogating (PLG): A NIAID-DAIDS Immunology Quality Assessment Program study. Cytometry Part B (Clin Cytometry) 2008; 74B ( Suppl). In press doi: 10.1002/cyto.b.20417 (this issue).
  • 22
    CLSI. Laboratory documents: Enumeration of immunologically defined cell populations by flow cytometry. Approved Guideline, 2nd ed. CLSI document H42-A2. Wayne, PA: CLSI; 2007.
  • 23
    Strauss K,Hannet I,Engels S,Shiba A,Ward DM,Ullery S,Jinguji MG,Valinsky J,Barnett D,Orfao A,Kestens L. Performance evaluation of the FACSCount System: A dedicated system for clinical cellular analysis. Cytometry 1996; 26: 5259.
  • 24
    O'Gorman MRG,Zijenah LS. The role of CD4 T cell measurements in the management of anti-retroviral therapy—A review with an emphasis on pediatric patients. Cytometry Part B (Clin Cytometry) 2008; 74B ( Suppl). In press. doi: 10.1002/cyto.b.20398 (this issue).
  • 25
    Lynen L,Teav S,Vereecken C,De Munter P,An S,Jacques G,Kestens L. Validation of primary CD4 gating as an affordable strategy for absolute CD4 counting in Cambodia. J AIDS 2006; 43: 179185.
  • 26
    Spacek LA,Shihab HM,Lutwama F,Summerton J,Mayanja H,Kamya M,Ronald A,Margolick JB,Nilles TL,Quinn TC. Evaluation of a low-cost method, the Guava EasyCD4 assay, to enumerate CD4-positive lymphocyte counts in HIV-infected patients in the United States and Uganda. J AIDS 2006; 41: 607610.
  • 27
    Goldie SJ,Yazdanpanah Y,Losina E,Weinstein MC,Anglaret X,Walensky RP,Hsu HE,Kimmel A,Holmes C,Kaplan JE,Freedberg KA. Cost-effectiveness of HIV treatment in resource-poor settings—the case of Côte d'Ivoire. N Engl J Med 2006; 355: 11411153.
  • 28
    Taiwo BO,Murphy RL. Clinical applications and availability of CD4+ T cell count testing in sub-Saharan Africa. Cytometry Part B (Clin Cytometry) 2008; 74B ( Suppl). In press. doi: 10.1002/cyto.b. 20383 (this issue).
  • 29
    World Health Organization. Emergency scale-up of antiretroviral therapy in resource-poor settings: Technical operational recommendations to achieve 3 by 5; 2004.http://www.who.int/3by5/publications/documents/en/zambiaen.pdf.
  • 30
    Glencross DK,Aggett HM,Stevens WS,Bergeron M,Mandy F. African regional external quality assessment (AFREQAS) for CD4 T-cell enumeration: Development, outcomes, and performance of laboratories. Cytometry Part B (Clin Cytometry) 2008; 74B ( Suppl). In press. doi: 10.1002/cyto.b.20397 (this issue).
  • 31
    Petti CA,Polage CR,Quinn TC,Ronald AR,Sande MA. Laboratory medicine in Africa: A barrier to effective health care. Clin Infect Dis 2006; 42: 377382.
  • 32
    Oman CB,Gamaniel KS,Addy ME. Properly functioning scientific equipment in developing countries. Anal Chem 78: 52735276.
  • 33
    Larsen CH. The fragile environments of Inexpensive CD4+ T cell enumeration in the least developed countries (LDC): Strategies for accessible support. Cytometry Part B (Clin Cytometry) 2008; 74B ( Suppl). In press. doi: 10.1002/cyto.b.20386 (this issue).
  • 34
    Didier JM,Kazatchkine MD,Demouchy C,Moat C,Diagbouga S,Sepulveda C,Di Lonardo AM,Weiss L. Comparative assessment of five alternative methods for CD4+ T-lymphocyte enumeration for implementation in developing countries. J AIDS 2001; 26: 193195.
  • 35
    Benatar SR. Health care reform and the crisis of HIV and AIDS in South Africa. N Engl J Med 2004; 351: 8192.
  • 36
    Samb B,Celletti F,Holloway J,Van Damme W,De Cock KM,Dybul M. Rapid expansion of the health workforce in response to the HIV epidemic. N Engl J Med 2007; 357: 25102514.
  • 37
    Manian BS. Affordable diagnostics: Changing the paradigm in India. Cytometry Part B (Clin Cytometry) 2008; 74B ( Suppl). In press. doi: 10.1002/cyto.b.20402 (this issue).
  • 38
    Abayomi A,Landis RC. Flow cytometry as the spearhead for delivering sustainable and versatile laboratory services to HIV-burdened health care systems of the developing world: A Caribbean model with potentially universal application. Cytometry Part B (Clin Cytometry) 2008; 74B ( Suppl). In press. doi: 10.1002/cyto.b. 20400 (this issue).
  • 39
    Jani IV,Janossy G,Brown DW,Mandy F. Multiplexed immunoassays by flow cytometry for diagnosis and surveillance of infectious diseases in resource-poor settings. Lancet Infect Dis 2002; 2: 243250.
  • 40
    Janossy G. The changing pattern of “smart” flow cytometry (S-FC) to assist the cost-effective diagnosis of HIV, tuberculosis and leukemias in resource-restricted conditions. Biotechnol J 2008; 3: doi: 10.1002.biot 200700200.
  • 41
    Glencross DK,Janossy G,Lawrie D,Coetzee LM,Scott LE,Sanne I,McIntyre JA,Stevens W. CD8/CD38 activation yields important clinical information of effective anti-retroviral therapy (ART): Findings from the first year of the CIPRA-SA cohort. Cytometry Part B (Clin Cytometry) 2008; 74B ( Suppl). In press. doi: 10.1002/cyto.b.20391 (this issue).
  • 42
    Streitz M,Tesfa L,Yildirim V,Yahyazadeh A,Ulrichs T,Lenkei R,Quassem A,Liebetrau G,Nomura L,Maecker H,Volk HD,Kern F. Loss of receptor on tuberculin-reactive T-cells marks active pulmonary TB. PLoS ONE 2007; 2: e735.
  • 43
    Shapiro HM: “Cellular astronomy”—A foreseeable future in cytometry. Cytometry Part A 2004; 60A: 115124.
  • 44
    Shapiro HM,Perlmutter NG. Personal cytometers—Slow flow or no flow? Cytometry Part A 2006; 69A: 620630.
  • 45
    Rodriguez WR,Christodoulides N,Floriano PN,Graham S,Mohanty S,Dixon M,Hsiang M,Peter T,Zavahir S,Thior I,Romanovicz D,Bernard B,Goodey AP,Walker BD,McDevitt JT. A microchip CD4 counting method for HIV monitoring in resource-poor settings. PLoS Med 2005; 2: e182.
  • 46
    Ymeti A,Li X,Lunter B,Breukers C,Tibbe AG,Terstappen LW,Greve J. A single platform image cytometer for resource-poor settings to monitor disease progression in HIV infection. Cytometry Part A 2007; 71A: 132142.
  • 47
    Li X,Tibbe AG,Droog E,Terstappen LW,Greve J. An immunomagnetic single-platform image cytometer for cell enumeration basedon antibody specificity. Clin Vaccine Immunol 2007; 14: 412419.
  • 48
    Li X,Ymeti A,Lunter B,Breukers C,Tibbe AG,Terstappen LW,Greve J. CD4(+) T lymphocytes enumeration by an easy-to-use single platform image cytometer for HIV monitoring in resource-constrained settings. Cytometry Part B (Clin Cytometry) 2007; 72B: 397407.